Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02669173
Title Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

high grade glioma

Therapies

Bevacizumab + Capecitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.